Knox News Featuring New Day Diagnostics’ ColoHealth

Today the Knox News featured a profile on ColoHealth, a stool-free colorectal cancer screening method created by our investment New Day Diagnostics (EDP Biotech). We’re so excited about this feature and hope you’ll click over to the Knox News website to read. Here’s a excerpt from the article—read the whole thing by clicking the button below.

The U.S. Preventive Services Task Force recommends all Americans over the age of 45 get a colonoscopy every 10 years, but around 30% of eligible U.S. adults have never been screened for colorectal cancer.

That's a major roadblock to reducing colorectal cancer cases and death. In 2023, there were approximately 150,000 new cases and over 50,000 deaths from colorectal cancer in the U.S. In Tennessee, three people die every day from colorectal cancer. It is also becoming more common in young adults.

"There are certain communities and subgroups in the East Tennessee area that have even higher instances of colorectal cancers, so we know that this is really important," Eric Mayer, CEO and president of New Day Diagnostics, told Knox News. "We understand that this is a need in our community specifically."

For now, New Day is testing all ColoHealth blood samples at its lab in Knoxville. Mayer said he expects the FDA to transfer approval to the test's new name this summer after the lab gathers more data.

"Eventually, it will be ready at doctors' offices around the country. For our initial launch this month, we are requesting everyone come here to our home base in Knoxville," Mayer said.